Literature DB >> 922663

Small cell cancer of the uterine cervix.

J R Van Nagell, E S Donaldson, E G Wood, Y Maruyama, J Utley.   

Abstract

Forty-one patients with small cell carcinoma of the uterine cervix were evaluated and treated at the University of Kentucky Medical Center from 1962 to 1974. Eighteen patients (44%) developed widespread metastases and died of recurrent cancer within 2 years of therapy. Common sites of metastases included the lung, liver, and bone. There was a significantly lower incidence of lymphoplasmacytic infiltration in small cell cancers than the keratinizing or nonkeratinizing squanmous cell carcinomas of the cervix. In addition, there was a significant increase in the number of unstimulated regional lymph nodes in patients with small cell cancer when compared with the lymph nodes of patients with the other cell types of cervical cancer. These data suggest that small cell cancer of the cervix is a highly aggressive tumor similar to small cell carcinoma of the lung and behaves quite differently from other types of squamous cell carcinoma of the cervix. Radiation therapy was superior to radical surgery in eradicating pelvic disease, but prospective studies need to be undertaken to determine the effect of adjunctive chemotherapy in patients with this rare tumor.

Entities:  

Mesh:

Year:  1977        PMID: 922663     DOI: 10.1002/1097-0142(197711)40:5<2243::aid-cncr2820400534>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

Review 1.  Extrapulmonary small cell carcinoma.

Authors:  J A Ledermann
Journal:  Postgrad Med J       Date:  1992-02       Impact factor: 2.401

2.  Clinicopathological features and prognosis of small cell carcinoma of the cervix.

Authors:  Jie Liu; Yuan Li; Shuang Li; Dan Wang; Ting Hu; Yuhan Meng; Ding Ma; Hongbing Cai; Zehua Wang; Chengliang Xiong; Huiping Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-11-10

3.  A novel human glassy-cell carcinoma cell line producing IL-6 and IL-8 from uterine cervix.

Authors:  A Oki; M Nishida; T Satoh; H Tsunoda; K Kasahara; K Saijo; T Kubo; T Ohno
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-04       Impact factor: 2.416

4.  Histological grading and DNA content as predictors of distant metastases in squamous cell carcinoma of the uterine cervix.

Authors:  M Anton; R Nenutil; J Zaloudík
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

5.  Chromogranin A (CgA) as poor prognostic factor in patients with small cell carcinoma of the cervix: results of a retrospective study of 293 patients.

Authors:  Ling-Min Liao; Xin Zhang; Yu-Feng Ren; Xiao-Ying Sun; Na Di; Nan Zhou; Rui-Ke Pan; Shu-Hua Ma; Li-Xue Zhou
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

6.  Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix.

Authors:  Long Huang; Jia-Xin Lin; Yan-Hong Yu; Mei-Yin Zhang; Hui-Yun Wang; Min Zheng
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

7.  Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosis.

Authors:  D J Cole; D C Brown; E Crossley; C J Alcock; K C Gatter
Journal:  Br J Cancer       Date:  1992-05       Impact factor: 7.640

8.  Carcinoma of the cervix uteri: an assessment of tumour proliferation using the monoclonal antibody Ki67.

Authors:  D C Brown; D Cole; K C Gatter; D Y Mason
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

9.  Malignancy grading in squamous carcinoma of uterine cervix treated by surgery.

Authors:  C A Pagnini; P Della Palma; G De Laurentiis
Journal:  Br J Cancer       Date:  1980-03       Impact factor: 7.640

10.  Analysis of the impact of platinum-based combination chemotherapy in small cell cervical carcinoma: a multicenter retrospective study in Chinese patients.

Authors:  Long Huang; Ling-Min Liao; An-Wen Liu; Jian-Bing Wu; Xiao-Ling Cheng; Jia-Xin Lin; Min Zheng
Journal:  BMC Cancer       Date:  2014-02-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.